News
Sandgaard reiterated confidence in the NiCO pulse oximeter, with FDA approval anticipated within six months of submission. He projected commercialization and revenue generation to begin in 2026. Q1 ...
Q1 2025 Management View CEO Bruce McClelland highlighted the continued momentum in the Cloud & Edge business, describing it ...
Q1 2025 Results Conference Call April 29, 2025 4:30 PM ETCompany ParticipantsCody McAllister - ICRJason Brooks - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback